Clinical Trial Update: A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)

View source ↗

Summary

A long-term prospective follow-up study for the CATO trial (SAS30018/SER9702) in asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Status: COMPLETED